Tracked deals
12
12 tracked deals across 2019-2024.
Oakdale, Minnesota, United States
Full-service CDMO offering CMC development, CTM manufacturing, regulatory compliance, consulting, and facility support via a nationwide network of CDMO sites, FDA-registered GMP analytical labs, and service centers for pharmaceutical, biopharmaceutical, and gene therapy programs.
Tracked deals
12
12 tracked deals across 2019-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
7 addon · 4 buyout · 1 divestiture
Last 6 years
Supporting Data
Pace Life Sciences, a PE-backed CDMO, has acquired Catalent’s Center-of-Excellence for Small Molecule Analytical Services located in Research Triangle Park, North Carolina. The acquisition expands Pace Life Sciences’ national analytical testing network (to nine sites) and strengthens its small- and large-molecule analytical capabilities to support biopharma clients; Catalent sold the site as part of its portfolio adjustments.
Pace Analytical Services, a division of Pace and a portfolio company of Leonard Green & Partners and Aurora Capital Partners, has acquired New Jersey-based Prestige EnviroMicrobiology, Inc. The acquisition expands Pace's Building Sciences capabilities by adding Prestige's specialized environmental microbiology and indoor air quality testing expertise.
Pace Analytical Services, a division of Pace and a PE-backed national laboratory network, has acquired Alpha Analytical, LLC, a full-service environmental laboratory based in Westborough, Massachusetts. The deal expands Pace's geographic footprint and laboratory capabilities in the Northeast, adding multiple labs and service centers and strengthening testing services for emerging contaminants such as PFAS.
Pace Analytical Services, a division of Pace, has acquired Aqua Pro‑Tech Laboratory (APL), an environmental testing laboratory in Fairfield, New Jersey. The APL location will become a primary Pace lab for New Jersey and New York City customers, expanding geographic coverage and testing capabilities (including PFAS and air/stack emissions testing).
Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.
Pace Life Sciences, a CDMO and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, a validation, regulatory, and compliance consulting provider based in Frederick, Maryland. The deal expands Pace's regulatory, quality and validation capabilities to better support biotechnology and pharmaceutical clients across development and commercialization.
Pace Analytical Services, a portfolio company of Aurora Capital Partners, has acquired ProScience Analytical Services, a Woburn, Massachusetts environmental testing laboratory. The deal adds Transmission Electron Microscopy (TEM) capability to Pace's laboratory network and expands its lead and asbestos testing presence in New England.
Pace Analytical Life Sciences, a CDMO subsidiary of Pace Analytical Services (itself a portfolio company of Aurora Capital Partners), has acquired Drug Delivery Experts, LLC, a San Diego-based CDMO specializing in complex injectable formulations and drug‑device combination product development. The acquisition expands Pace’s injectable and long‑acting/extended‑release capabilities and brings DDE’s scientific leadership into Pace’s west‑coast operations as DDE transitions to the Pace brand.
Pace Analytical Life Sciences, a subsidiary of Pace Analytical Services, acquired Bio-Concept Laboratories, a Salem, New Hampshire-based pharmaceutical CDMO specializing in sterile aqueous formulation development and fill–finish manufacturing. The deal expands Pace’s sterile materials and ophthalmic manufacturing capabilities to better support clinical trial and drug development programs and strengthens its New England CDMO footprint.
Pace Analytical Services, LLC acquired Emerson Resources, Inc., a CDMO specializing in solid oral dosage development and cGMP clinical trial material manufacturing. The acquisition expands Pace Life Sciences' capabilities to include clinical trial material production and transitions Emerson's Norristown, Pennsylvania lab into the Pace Analytical network while Emerson principals exit the business.
Pace Analytical Services, LLC acquired Aerobiology Laboratory Associates, Inc., an accredited environmental microbiology testing laboratory with eight labs and two service centers, to strengthen Pace’s microbiology capabilities. Aerobiology will continue operating under its brand as a division of Pace, with founder Suzanne Blevins and her team remaining to lead the business.
Pace Analytical Services, LLC acquired Shealy Environmental Services, Inc., a full-service environmental testing laboratory based in West Columbia, South Carolina. The acquisition expands Pace’s laboratory network and PFAS testing and federal program capabilities in the Southeast U.S.; Shealy’s management will remain on site to lead the location.
Turn tracked acquisition activity into an outreach-ready buyer list.